期刊文献+

2种三联疗法根除幽门螺杆菌感染胃溃疡临床疗效比较 被引量:29

Comparison of Clinic Curative Effect of Two Kinds of Triple Therapies on Eradication of Gastric Ulcer Infected with Helicobacter Pylori
下载PDF
导出
摘要 目的通过比较2种治疗胃溃疡的三联疗法的治愈率和幽门螺杆菌根除率,探讨较为理想的胃溃疡治疗和幽门螺杆菌根除方案。方法选取120例感染了幽门螺杆菌的胃溃疡患者,采用随机数字表法分为A、B 2组,每组60例,分别接受硫糖铝、洛赛克和阿莫西林2周三联疗法和硫糖铝、甲硝唑和克拉霉素2周三联疗法治疗,治疗结束后4周应用胃镜和活检染色对溃疡治愈率和幽门螺杆菌根除率进行分析。结果A、B 2组患者溃疡治愈率差异无统计学意义(91.67%vs 81.67%,P>0.05),但A组患者幽门螺杆菌根除率要高于B组(95.00%vs81.67%,P<0.05)。结论硫糖铝、洛赛克和阿莫西林2周三联疗法是一种更为理想的胃溃疡治疗方案。 Objective To explore a more ideal program of treatment of gastric ulcer and Helicobacter pylori eradication by comparing the cure rate and the Helicobacter pylori eradication rate of two kinds of triple therapies for gastric ulcer.Methods One hundred twenty patients with gastric ulcer infected with Helicobacter pylori were divided into groups A and B by random table method,and were treated with sucralfate,omeprazole and amoxicillin for two weeks for group A(n=60)or sucralfate,metronidazole and clarithromycin for two weeks for groups B(n=60),respectively.The endoscopy and biopsy staining were used to analysis the cure rate and the Helicobacter pylori eradication rate at the 4th week after the end of the treatment.Results There was no difference between groups A and B in gastric ulcer cure rate(91.67% vs 81.67%,P0.05),but the Helicobacter pylori eradication rate of group A was higher than that of group B(95.00% vs 81.67%,P0.05).Conclusion Sucralfate,omeprazole and amoxicillin two-week triple therapy is a more ideal treatment program for gastric ulcer.
作者 蒋志坚
出处 《实用临床医学(江西)》 CAS 2010年第6期20-21,23,共3页 Practical Clinical Medicine
关键词 三联疗法 胃溃疡 疗效 幽门螺杆菌 triple therapy gastric ulcer curative effect Helicobacter pylori
  • 相关文献

参考文献6

二级参考文献49

  • 1CHENXue-jun,YANJie,SHENYue-fang.Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases[J].Chinese Medical Journal,2005(6):460-467. 被引量:6
  • 2李守杰.维生素B1缺乏症1例[J].实用儿科临床杂志,1995,10(1):32-33.
  • 3Gisbert JP, Pajares JM. Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis. Dig Liver Dis, 2004,36,253-259.
  • 4Tulassay Z, Kryszewsk A, Dite P, et al. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal Ulcer disease. Eur J Gastroenterol Hepatol, 2001, 13:1457-1465.
  • 5Taylor D E.Zhongming Ge.Dale Purych.et al.Cloning and Sequence Analysis of Two Copies of a 23S rRNA Cene from Helicobacter pylori and Association of Clarithromycin Resistance with 23S rRNA Mutations,Antimicrobial Agents And Chemotherapy,1997,41(12):2621
  • 6Gerrits MM,de Zoete MR,Arents NL,et al.16S rRNA Mutation-Mediated Tetracycline Resistance in Helicobacter pylori.Antimicrob Agenta Chemother,2002,46(9):2996
  • 7Catharine A,Trieber DE,Taylor,et al.Mutations in the 16S rRNA Genes of Helicobaeter pylori Mediate Resistance to Tetracycline.Journal of Bacteriology,2002,184(8):2131
  • 8Dailidiene D,Bertoli MT,Miciuleviciene J,et al.Emergence of tetracycline resistance in Helicobacter pylori:multiple mutational changes in 16S ribosomal DNA and other genetic loci Antimicrob.Agents Chemother,2002,46(12):3940
  • 9Nonaka L,Connell SR,Taylor DE,et al.16S rRNA Mutations That Confer Tetracycline Resistance in Helicobacter pylori Decrease Drug Binding in Escherichia coli Ribosomes.J Bacteriology,2005,189(11):3708
  • 10Wu JY,Kim JJ,Reddy R,et al.Tetracycline-Resistant Clinical Helicobacter pylori Isolates with and without Mutation in 16S rRNA-Encoding Genes.Antimicrob Agents Chemother,2005,49(2):578

共引文献162

同被引文献193

引证文献29

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部